...
机译:奥氮平结合酶法对精神分裂症体重增加的影响:24周第3期研究。
Department of Psychiatry Zucker Hillside Hospital Northwell Health;
Department of Psychiatry Zucker Hillside Hospital Northwell Health;
Department of Psychiatry Zucker Hillside Hospital Northwell Health;
Department of Psychiatry Zucker Hillside Hospital Northwell Health;
Department of Psychiatry Zucker Hillside Hospital Northwell Health;
Department of Psychiatry Zucker Hillside Hospital Northwell Health;
Department of Psychiatry Zucker Hillside Hospital Northwell Health;
Department of Psychiatry Zucker Hillside Hospital Northwell Health;
Department of Psychiatry Zucker Hillside Hospital Northwell Health;
Department of Psychiatry Zucker Hillside Hospital Northwell Health;
Department of Psychiatry Zucker Hillside Hospital Northwell Health;
Antipsychotic Agents; Olanzapine; Samidorphan; Schizophrenia; Weight Gain;
机译:奥氮平诱导的体重增加的减轻亚己醛,一种阿片类药物拮抗剂:精神分裂症患者的随机双盲相2研究
机译:奥氮平治疗精神分裂症或躁郁症患者体重增加的相关因素:一项为期六个月的前瞻性,跨国,观察性研究的结果。
机译:在未经药物治疗的首发精神分裂症患者中,二甲双胍的添加减轻了奥氮平诱导的体重增加:一项双盲,安慰剂对照研究。
机译:精神分裂症期奥氮平口服分散片(ODT)的新型药物传递方法。
机译:移民状况和孕产妇健康行为对妊娠体重增加的影响以及对医学研究所妊娠体重增加建议的坚持
机译:Samidorphan可减轻olanzapine引起的体重增加和代谢大鼠和非人类灵长类动物的功能障碍
机译:100个精神分裂症的100奥兰扎滨/ Samidorphan:体重增加和第3阶段启蒙-2和随后的长期开放式安全研究中的重量增益和代谢结果
机译:美国空军的食物习惯研究。第三部分。体重增加和超重的食物偏好